iSpecimen Inc. (ISPC) Misses Q2 EPS by 9c

iSpecimen Inc. (NASDAQ: ISPC) reported Q2 EPS of ($0.39), $0.09 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $1.63 million versus the consensus estimate of $3.07 million.

For earnings history and earnings-related data on iSpecimen Inc. (ISPC) click here.

You May Also Be Interested In

• Ciena beats estimates on strong AI-driven demand, shares rise
• CarGurus names Matthew Mandel as CFO, effective Oct. 19
• Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance